Health officials announced on Thursday that a 34-year-old woman in southeastern Australia had died of a rare coagulopathy after receiving the first dose of the AstraZeneca vaccine.
The Therapeutic Goods Administration of Australia (TGA) stated that the New South Wales (NSW) woman, who did not want to be named, died of thrombosis and thrombocytopenia (TTS) on Wednesday, which “may be related to” the UK-Sweden Related to the COVID-19 vaccine.in a statement.
“TGA extends its most sincere condolences to her family and loved ones. We are in close communication with the New South Wales Department of Health and they are conducting further investigations into this case,” TGA said.
The government agency did not disclose other details-such as the woman’s basic health status.
“TTS is a rare event involving a severe blood clot with a low platelet count. It is triggered by the immune system’s response to the AstraZeneca vaccine and is different from other clotting conditions,” TGA explained.
The agency pointed out that the most common time period for TTS symptoms to appear is 4 to 30 days after vaccination.
From the 425 reports received and reviewed by TGA from the launch of the vaccine to August 1st, 7 death reports that may be related to vaccination were found. 9 News famous. Six of the deaths that occurred after the first dose of the AstraZeneca vaccine were confirmed as TTS cases, and one was with immune thrombocytopenia (ITP).
Five of the six TTS deaths were women between the ages of 34 and 72, and the only male death was 44 years old.
This woman is the third confirmed or probable TTS case reported by TGA in the week ending August 5, of which a 51-year-old New South Wales woman was the second confirmed case, and a 67-year-old Victorian woman was Assess as a possible situation.
According to the agency, these cases were evaluated using the UK case definition.
“This has increased the total number of Australian reports assessed as TTS after AstraZeneca vaccination from approximately 6.8 million doses to 93 cases (57 confirmed cases, 36 possible cases),” TGA said.
The health agency stated that severe cases of TTS appear to be more common among young women. It added that nearly half of female TTS cases require intensive care.
In recent weeks, the promotion of AstraZeneca vaccines in Australia, especially in New South Wales, has increased. 7 News Report.
According to Australian media reports, there were 5 COVID-19-related deaths and 262 local cases on Thursday alone.
According to the TGA report, as of Sunday, Australia has received approximately 12.4 million doses of the vaccine-divided into 8.4 million doses of the first dose and 4 million doses of the second dose.
Express. The 34-year-old woman’s rare coagulopathy is “probably related” to the AstraZeneca vaccine.
Photo: Pixabay
